Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation

Shota Kawakami, Kazuhiko Ochiai, Yuiko Kato, Masaki Michishita, Hinako Hirama, Ryo Obara, Daigo Azakami, Masami Watanabe, Toshinori Omi

Research output: Contribution to journalArticlepeer-review


Gliomas are common intracranial neoplasias in dogs. However, the underlying pathogenic mechanisms remain unclear. In humans, isocitrate dehydrogenase 2 (IDH2) is often mutated in gliomas. Although almost human IDH2 mutations have been identified at the Arg172 codon, few studies have reported structural, functional or mutational information for canine IDH2. In this study, we cloned the full-length canine IDH2 (cIDH2) cDNA and substituted wild type Arg174 (cIDH2 WT: corresponding to R172 of human IDH2) with Lys (cIDH2 R174K). The cIDH2 WT and R174K proteins were overexpressed in HeLa cells, and their presence was confirmed using an anti-human IDH2-WT mAb (clone: KrMab-3) and an anti-IDH2-R172K mAb (clone: KMab-1). The IDH2 activity between cIDH2 WT and cIDH2 R174K transfectants was compared by measuring the production of NADH and NADPH. NADPH production was lower for cIDH2 R174K than that for cIDH2 WT transfectants. Finally, we detected increased expression of hypoxia inducible factor-1 alpha (HIF-1α) in cIDH2 R174K transfectants. This indicates that mutations at R174 can potentially induce carcinogenesis in canine somatic cells.

Original languageEnglish
Pages (from-to)85-91
Number of pages7
JournalJournal of Veterinary Medical Science
Issue number1
Publication statusPublished - 2018


  • Canine
  • Glioma
  • IDH2
  • Mutation

ASJC Scopus subject areas

  • General Veterinary


Dive into the research topics of 'Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation'. Together they form a unique fingerprint.

Cite this